Safety and Efficacy of Lidocaine 5% Medicated Plaster in Comparison to Systemic Treatment in Postherpetic Neuralgia and Diabetic Polyneuropathic Pain.

NCT00414349 Phase 3 COMPLETED

The purpose of this study is to evaluate lidocaine as topical treatment for peripheral neuropathic pain (as stand-alone treatment and in combination with systemic treatment)

Details

Lead sponsor	Grünenthal GmbH
Phase	Phase 3
Status	COMPLETED
Enrolment	431
Start date	2006-12
Completion	2008-03

Conditions

• Neuropathic Pain

Interventions

• Topical analgesic
• oral intake
• Topical analgesic

Primary outcomes

• Reduction of pain expressed by response rate after 4 weeks treatment every 4 weeks of single or combination treatment: change in neuropathic pain, change in quality of life, change in sleep quality — 4 weeks

Countries

United Kingdom